These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12919751)

  • 21. Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals.
    Greenier JL; Van Rompay KK; Montefiori D; Earl P; Moss B; Marthas ML
    Virol J; 2005 Feb; 2():11. PubMed ID: 15710048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
    Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
    Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The genetic fate of molecularly cloned simian immunodeficiency virus in experimentally infected macaques.
    Johnson PR; Hamm TE; Goldstein S; Kitov S; Hirsch VM
    Virology; 1991 Nov; 185(1):217-28. PubMed ID: 1926774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncated forms of human and simian immunodeficiency virus in infected individuals and rhesus macaques are unique or rare quasispecies.
    Pion M; Sanchez G; Liska V; Bettendroffer L; Candotti D; Chenine AL; Gondois-Rey F; Tamalet C; Vigne R; Ruprecht RM; Agut H; Hirsch I;
    Virology; 2003 Jun; 311(1):157-68. PubMed ID: 12832213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles.
    Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M
    Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
    Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
    J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking the Emergence of Host-Specific Simian Immunodeficiency Virus env and nef Populations Reveals nef Early Adaptation and Convergent Evolution in Brain of Naturally Progressing Rhesus Macaques.
    Lamers SL; Nolan DJ; Rife BD; Fogel GB; McGrath MS; Burdo TH; Autissier P; Williams KC; Goodenow MM; Salemi M
    J Virol; 2015 Aug; 89(16):8484-96. PubMed ID: 26041280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and induction of immune responses by a DNA AIDS vaccine.
    Smith JM; Leung NJ; Torres JV
    Viral Immunol; 2000; 13(3):343-51. PubMed ID: 11016598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectivity of wild-type and deleted proviral SIV DNA.
    Purcell DF; Cameron PU; Mills J; Kent S
    Dev Biol (Basel); 2001; 106():395-406. PubMed ID: 11761255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology.
    Chen MF; Westmoreland S; Ryzhova EV; Martín-García J; Soldan SS; Lackner A; González-Scarano F
    J Neurovirol; 2006 Apr; 12(2):73-89. PubMed ID: 16798669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection of macaques with a molecular clone, SHIVSF33A2, provides evidence for tissue specific variants.
    Buckner CM; Gettie A; Tan RC; Eshetu T; Ratterree M; Blanchard J; Cheng-Mayer C; Harouse JM
    J Med Primatol; 2002 Aug; 31(4-5):164-70. PubMed ID: 12390538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.
    Dehghani H; Puffer BA; Doms RW; Hirsch VM
    J Virol; 2003 Jun; 77(11):6405-18. PubMed ID: 12743298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.
    Fuller DH; Rajakumar PA; Wilson LA; Trichel AM; Fuller JT; Shipley T; Wu MS; Weis K; Rinaldo CR; Haynes JR; Murphey-Corb M
    J Virol; 2002 Apr; 76(7):3309-17. PubMed ID: 11884556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of SIV in tissues from experimentally infected macaques.
    Hirsch VM; Zack PM; Johnson PR
    J Med Primatol; 1990; 19(3-4):287-94. PubMed ID: 2231685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral RNA levels and env variants in semen and tissues of mature male rhesus macaques infected with SIV by penile inoculation.
    Fieni F; Stone M; Ma ZM; Dutra J; Fritts L; Miller CJ
    PLoS One; 2013; 8(10):e76367. PubMed ID: 24146859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.